Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press27710.17650/1994-4098-2010-0-4-98-102GYNECOLOGY. TREATMENTГИНЕКОЛОГИЯ. ЛЕЧЕНИЕCytoreductive interventions in combination with hyperthermic intraperitoneal chemoperfusion in pseudomyxomaЦиторедуктивные вмешательства в сочетании с гипертермической интраперитонеальной химиоперфузией при псевдомиксомеAbdullayevA. G.АбдуллаевА. Г.
Russian Federation
agulsky@rambler.ruGorbunovaV. A.ГорбуноваВ. А.
Russian Federation
Ter-OvanesovM. D.Тер-ОванесовМ. Д.
Russian Federation
PolotskyB. E.ПолоцкийБ. Е.
Russian Federation
BuidenokYu. V.БуйденокЮ. В.
Russian Federation
DavydovM. I.ДавыдовМ. И.
Russian Federation
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowГУ РОНЦ им. Н.Н. Блохина, Москва2911201049810201092014010920142010https://ojrs.abvpress.ru/ojrs/article/view/277

The tolerability and efficiency of peritonectomy in combination with hyperthermic intraperitoneal chemoperfusion were studied in patients with pseudomyxoma peritonei. Data from 10 patients were analyzed. The pattern of complications classified as surgical and chemotherapy- associated ones is presented. The long-term results of treatment are demonstrated.

Проведено исследование по изучению переносимости и эффективности выполнения перитонэктомии в сочетании с гипертермической интраперитонеальной химиоперфузией у больных псевдомиксомой брюшины. Проанализированы данные 10 пациентов. Представлена структура осложнений, которые подразделяют на хирургические и осложнения, связанные с проведением химиотерапии. Продемонстрированы отдаленные результаты лечения.

pseudomyxoma peritoneihyperthermic intraperitoneal chemoperfusionperitonectomyпсевдомиксома брюшиныгипертермическая интраперитонеальная химиоперфузияперитонэктомия1. Moran B.J., Cecil T.D. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003;12:585–603.Moran B.J., Cecil T.D. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003;12:585–603.2. Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006;7:69–76.Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006;7:69–76.3. Weaver C.H. Mucocele of the appendix with pseudomucinous degeneration. Am J Surg 1937;36:523–6.Weaver C.H. Mucocele of the appendix with pseudomucinous degeneration. Am J Surg 1937;36:523–6.4. Misdraji J., Yantiss R.K., Graeme-Cook F.M. et al. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003;27:1089–103.Misdraji J., Yantiss R.K., Graeme-Cook F.M. et al. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol 2003;27:1089–103.5. Carr N.J., Emory T.S., Sobin L.H. Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apaptosis and expression of p53, CD44, bcl-2. Arch Pathol Lab Med 2002;126:837–41.Carr N.J., Emory T.S., Sobin L.H. Epithelial neoplasms of the appendix and colorectum: an analysis of cell proliferation, apaptosis and expression of p53, CD44, bcl-2. Arch Pathol Lab Med 2002;126:837–41.6. Ronnett B.M., Zahn C.M., Kurman R.J. et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to «pseudomyxoma peritonei». Am J Surg Pathol 1995;19:1390–408.Ronnett B.M., Zahn C.M., Kurman R.J. et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to «pseudomyxoma peritonei». Am J Surg Pathol 1995;19:1390–408.7. Chejfec G., Rieker W.J., Jablokow V.R. et al. Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas. Gastroenterology 1986;90:202–5.Chejfec G., Rieker W.J., Jablokow V.R. et al. Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas. Gastroenterology 1986;90:202–5.8. Hawes D., Robinson R., Wira R. Pseudomyxoma peritonei from metastatic colloid carcinoma of the breast. Gastrointest Radiol 1991;16:80–2.Hawes D., Robinson R., Wira R. Pseudomyxoma peritonei from metastatic colloid carcinoma of the breast. Gastrointest Radiol 1991;16:80–2.9. Kahn M.A., Demopoulos R.I. Mucinous ovarian tumors with pseudomyxoma peritonei: a clinicopathological study. Int J Gynecol Pathol 1992;11:15–23.Kahn M.A., Demopoulos R.I. Mucinous ovarian tumors with pseudomyxoma peritonei: a clinicopathological study. Int J Gynecol Pathol 1992;11:15–23.10. Ronnett B.M., Seidman J.D. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol 2003;27:650–7.Ronnett B.M., Seidman J.D. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol 2003;27:650–7.11. Miner T.J., Shia J., Jaques D.P. et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005;241:300–8.Miner T.J., Shia J., Jaques D.P. et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005;241:300–8.12. Baratti D., Kusamura S., Nonaka D. et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 2008;15:526–34.Baratti D., Kusamura S., Nonaka D. et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 2008;15:526–34.13. Butterworth S.A., Panton N.M., Klaassen D.J. et al. Morbidity and mortality associated with intraperitoneal chemotherapy for pseudomyxoma peritonei. Am J Surg 2002;183:529–32.Butterworth S.A., Panton N.M., Klaassen D.J. et al. Morbidity and mortality associated with intraperitoneal chemotherapy for pseudomyxoma peritonei. Am J Surg 2002;183:529–32.14. Elias D., Lasser P., Reynard B. et al. Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy. Gastroenterol Clin Biol 2003;27:407–12.Elias D., Lasser P., Reynard B. et al. Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy. Gastroenterol Clin Biol 2003;27:407–12.15. Gonzalez-Moreno S., Sugarbaker P.H. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg 2004;91:304–11.Gonzalez-Moreno S., Sugarbaker P.H. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg 2004;91:304–11.16. Guner Z., Schmidt U., Dahlke M.H. et al. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis 2005;20:155–60.Guner Z., Schmidt U., Dahlke M.H. et al. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis 2005;20:155–60.17. Loungnarath R., Causeret S., Bossard N. et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonea: a prospective study. Dis Colon Rectum 2005;48:1372–9.Loungnarath R., Causeret S., Bossard N. et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonea: a prospective study. Dis Colon Rectum 2005;48:1372–9.18. Murphy E.M., Sexton R., Moran B.J. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum 2006;50:37– 42.Murphy E.M., Sexton R., Moran B.J. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum 2006;50:37– 42.19. Smeenk R.M., Verwaal V.J., Zoetmulder F.A. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei – a report of 103 procedures. Eur J Surg Oncol 2006;32:186–90.Smeenk R.M., Verwaal V.J., Zoetmulder F.A. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei – a report of 103 procedures. Eur J Surg Oncol 2006;32:186–90.20. Sugarbaker P.H., Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727–31.Sugarbaker P.H., Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727–31.21. Sugarbaker P.H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. Michigan: Ludann Company, 1998.Sugarbaker P.H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. Michigan: Ludann Company, 1998.